What is the most widely available brand of rosuvastatin 10 mg tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Rosuvastatin 10mg Brand Availability

Rosuvastatin 10mg is widely available as a generic medication from multiple manufacturers, with Crestor® being the original brand name product from AstraZeneca. 1

Brand and Generic Information

  • Crestor® is the original brand-name rosuvastatin licensed to AstraZeneca from Shionogi, and was the first formulation approved for clinical use 2

  • Generic rosuvastatin is now extensively available and widely used, with multiple manufacturers producing FDA-approved generic versions 1

  • The generic formulation has demonstrated comparable efficacy, safety, and clinical outcomes to brand-name statins, with the added benefit of approximately 16% reduction in medical expenses per patient 3

Physical Description of 10mg Tablets

The FDA-approved rosuvastatin 10mg tablets are described as: pink colored, round, biconvex, film-coated tablets 1

  • Generic versions may have different markings depending on the manufacturer (e.g., "SG on one side and 117 on other side" for one generic formulation) 1

Clinical Context for 10mg Dosing

  • Rosuvastatin 10mg is classified as moderate-intensity statin therapy, producing approximately 30-49% LDL-C reduction 4

  • This dose is appropriate for many patients requiring moderate-intensity therapy, including those with established atherosclerotic cardiovascular disease who cannot tolerate high-intensity therapy 4

  • The 10mg dose is the maximum recommended dose for patients taking certain concomitant medications (cyclosporine requires ≤5mg; teriflunomide, enasidenib, capmatinib, and regorafenib require ≤10mg) 1

Practical Considerations

  • Generic rosuvastatin is the most cost-effective option and should be preferentially used in most clinical scenarios 3

  • For Asian patients, 5mg is the recommended starting dose due to increased plasma concentrations, with careful consideration needed before escalating beyond 20mg 1

  • In patients with severe renal impairment (CrCl <30 mL/min/1.73 m²) not on hemodialysis, the starting dose is 5mg and should not exceed 10mg daily 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.